Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25074056 |
86 | 1 | |
Muscular weakness, Balance disorder, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 602 | 25074148 |
70 | 2 | |
Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 603 | 25061575 |
US |
1 | |
Inability to afford medication, Therapy interrupted, |
||||
APIXABAN, |
||||
| 604 | 25061619 |
US |
||
Dementia Alzheimer^s type, Therapy interrupted, |
||||
RELUGOLIX, AMLODIPINE, DOXAZOSIN, DOXAZOSIN MESYLATE, APIXABAN, FUROSEMIDE, |
||||
| 605 | 25061878 |
US |
1 | |
Hospitalisation, COVID-19, Intentional dose omission, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, |
||||
| 606 | 25061913 |
US |
63 | 2 |
Insurance issue, Therapy interrupted, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 607 | 25062114 |
RO |
62 | 2 |
Thrombocytopenia, Colorectal cancer metastatic, Rash, Skin toxicity, Therapy interrupted, |
||||
PANITUMUMAB, PANITUMUMAB, FLUOROURACIL, OXALIPLATIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 608 | 25062128 |
US |
1 | |
Hallucination, visual, Hallucination, Loss of personal independence in daily activities, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, AMANTADINE, |
||||
| 609 | 25062279 |
US |
2 | |
Hallucination, Hallucination, visual, Condition aggravated, Memory impairment, Incorrect dose administered, Product use issue, Therapy interrupted, Inability to afford medication, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 610 | 25062429 |
CO |
9 | 2 |
Therapy interrupted, Insurance issue, Breast enlargement, Breast pain, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 611 | 25062696 |
US |
82 | 2 |
Condition aggravated, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, VIBEGRON, PYRIDOSTIGMINE BROMIDE ORAL, |
||||
| 612 | 25063031 |
DK |
30 | 1 |
Drug ineffective, Weight increased, Increased need for sleep, Apathy, Akathisia, Hyperprolactinaemia, Sexual dysfunction, Therapy interrupted, Diabetes mellitus, Fatigue, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, RISPERIDONE, OLANZAPINE, CLOZAPINE, CLOZAPINE, AMISULPRIDE, AMISULPRIDE, |
||||
| 613 | 25063813 |
54 | 2 | |
Influenza, Surgery, Therapy interrupted, Product dispensing issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 614 | 25064427 |
US |
37 | 1 |
Knee operation, Flatulence, Sleep disorder, Abdominal pain upper, Depression, Malaise, Chest pain, Dry skin, Asthenia, Fatigue, Dry mouth, Headache, Decreased appetite, Diarrhoea, Polyuria, Thirst, Dizziness, Underdose, Product dose omission issue, Therapy interrupted, |
||||
TOLVAPTAN, TOLVAPTAN, CLONIDINE, DICYCLOMINE HYDROCHLORIDE, DIVALPROEX SODIUM, GABAPENTIN, LORAZEPAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ZOLPIDEM TARTRATE, |
||||
| 615 | 25064439 |
1 | ||
Haemoglobin decreased, Therapy interrupted, |
||||
IMATINIB, PANTOPRAZOLE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 616 | 25064723 |
US |
55 | 2 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 617 | 25065012 |
US |
2 | |
Condition aggravated, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 618 | 25065239 |
US |
58 | 1 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 619 | 25065429 |
US |
2 | |
Infection, Pain, Therapy interrupted, Inability to afford medication, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 620 | 25065613 |
US |
42 | 2 |
Hepatic cirrhosis, Hepatic encephalopathy, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, |
||||
| 621 | 25067521 |
47 | 1 | |
Influenza, Therapy interrupted, Nausea, Migraine, |
||||
AMBRISENTAN, SPIRONOLACTONE, CARVEDILOL, TADALAFIL, |
||||
| 622 | 25067608 |
50 | 2 | |
Therapy interrupted, Pruritus, Pruritus, Urticaria, Drug withdrawal syndrome, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SERTRALINE HYDROCHLORIDE, |
||||
| 623 | 25067612 |
66 | 2 | |
Herpes zoster, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 624 | 25067617 |
60 | 1 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 625 | 25067670 |
65 | 2 | |
COVID-19, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 626 | 25067764 |
68 | 2 | |
Illness, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 627 | 25067843 |
56 | 2 | |
Dyspnoea, Headache, Chest pain, Therapy interrupted, |
||||
ADALIMUMAB-BWWD, ADALIMUMAB-BWWD, |
||||
| 628 | 25067911 |
2 | ||
Cardiac operation, Therapy interrupted, |
||||
LENALIDOMIDE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, MAGNESIUM, ERGOCALCIFEROL, |
||||
| 629 | 25067944 |
63 | 2 | |
Illness, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 630 | 25068047 |
53 | 1 | |
Illness, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 631 | 25068405 |
69 | 2 | |
Infusion related reaction, Feeling hot, Erythema, Dyspnoea, Palpitations, Blood pressure systolic increased, Therapy interrupted, Infusion site pain, Headache, Chills, |
||||
DONANEMAB-AZBT, |
||||
| 632 | 25056607 |
US |
||
Full blood count decreased, Pulmonary oedema, Urinary tract infection, Drug ineffective, Underdose, Therapy interrupted, |
||||
OLAPARIB, |
||||
| 633 | 25056707 |
BR |
||
Dysphonia, Rhinorrhoea, Decreased immune responsiveness, Oropharyngeal pain, Influenza, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, AZATHIOPRINE, |
||||
| 634 | 25056834 |
US |
1 | |
Intentional product misuse, Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 635 | 25056927 |
US |
65 | 1 |
Death, Lung disorder, Dysgeusia, Therapy interrupted, Product dose omission issue, |
||||
AMIKACIN, AMIKACIN, |
||||
| 636 | 25057048 |
US |
2 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 637 | 25057428 |
GB |
2 | |
Mental impairment, Confusional state, Sedation, Therapy interrupted, Somnolence, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 638 | 25057540 |
TR |
24 | 1 |
Therapy interrupted, Drug dose omission by device, Product availability issue, |
||||
SOMATROPIN, |
||||
| 639 | 25057646 |
US |
2 | |
Drug ineffective, Inability to afford medication, Living in residential institution, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 640 | 25057663 |
US |
76 | 1 |
Device delivery system issue, Therapy interrupted, Pain, Incorrect dose administered by device, |
||||
ABATACEPT, |
||||
| 641 | 25057723 |
US |
2 | |
Loss of personal independence in daily activities, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 642 | 25058181 |
US |
81 | 2 |
Therapy interrupted, Product communication issue, Device difficult to use, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 643 | 25058263 |
US |
2 | |
Disturbance in attention, Patient dissatisfaction with treatment, Therapy interrupted, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 644 | 25058526 |
US |
2 | |
Rash, Discomfort, Therapy interrupted, |
||||
APREMILAST, APREMILAST, APREMILAST, |
||||
| 645 | 25058605 |
1 | ||
Crohn^s disease, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 646 | 25058708 |
78 | 2 | |
COVID-19, Therapy interrupted, |
||||
TOFACITINIB, |
||||
| 647 | 25058836 |
BR |
||
Cerebrovascular accident, Symptom recurrence, Scratch, Muscular weakness, Pain in extremity, Therapy interrupted, Intentional dose omission, |
||||
INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 648 | 25058860 |
US |
45 | 2 |
Dependence, Imprisonment, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 649 | 25058889 |
GB |
1 | |
Seizure, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 650 | 25058899 |
GB |
1 | |
Antipsychotic drug level decreased, Treatment noncompliance, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 651 | 25058991 |
US |
72 | 2 |
Product distribution issue, Upper respiratory tract infection, Pneumothorax, Weight decreased, Hyperhidrosis, Muscle spasms, Therapy interrupted, Muscle twitching, Noninfective gingivitis, Product dose omission in error, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 652 | 25059090 |
CO |
81 | 2 |
Muscle spasticity, Oxygen saturation decreased, Product dispensing issue, Therapy interrupted, |
||||
ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, |
||||
| 653 | 25059104 |
2 | ||
Pneumonia, Influenza, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 654 | 25059206 |
US |
55 | 2 |
Product supply issue, Therapy interrupted, Off label use, |
||||
THALIDOMIDE, |
||||
| 655 | 25059557 |
2 | ||
Therapy interrupted, Influenza virus test positive, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 656 | 25059597 |
GB |
1 | |
Blood creatine phosphokinase increased, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, LITHIUM, LITHIUM BROMATUM, RIVAROXABAN, |
||||
| 657 | 25059630 |
45 | 2 | |
Febrile neutropenia, Therapy interrupted, |
||||
RIBOCICLIB, |
||||
| 658 | 25059976 |
60 | 2 | |
Influenza, Respiratory tract infection, Therapy interrupted, |
||||
TOFACITINIB, |
||||
| 659 | 25060441 |
US |
50 | 2 |
Therapy interrupted, |
||||
APREMILAST, LORATADINE, LORATADINE ORAL, MELOXICAM, MIRABEGRON, OXYBUTYNIN, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, SEMAGLUTIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TIZANIDINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 660 | 25060620 |
US |
66 | 1 |
Diabetes mellitus inadequate control, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 661 | 25060706 |
US |
61 | 1 |
Product supply issue, Therapy interrupted, |
||||
| 662 | 25061013 |
CO |
81 | 2 |
Neoplasm, Off label use, Product dispensing issue, Therapy interrupted, |
||||
ROTIGOTINE, LEVOTHYROXINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVODOPA, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 663 | 25061166 |
US |
74 | 2 |
Adverse event, Diarrhoea, Headache, Insomnia, Therapy interrupted, Intentional product misuse, |
||||
APREMILAST, APREMILAST, |
||||
| 664 | 25062362 |
43 | 2 | |
Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 665 | 25062363 |
76 | 2 | |
Therapy interrupted, Influenza A virus test positive, Intentional dose omission, |
||||
ADALIMUMAB, |
||||
| 666 | 25062977 |
38 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 667 | 25062984 |
61 | 1 | |
COVID-19, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 668 | 25062985 |
70 | 2 | |
Exposure to SARS-CoV-2, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 669 | 25063070 |
76 | 2 | |
Swelling face, Rash, Pustule, Burning sensation, Hordeolum, Therapy interrupted, |
||||
EVOLOCUMAB, LEVOTHYROXINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, PANTOPRAZOLE, BISOPROLOL FUMARATE, EZETIMIBE, ROSUVASTATIN, MINOCYCLINE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 670 | 25063149 |
35 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 671 | 25063342 |
64 | 2 | |
Illness, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 672 | 25063588 |
40 | 1 | |
Insomnia, Therapy interrupted, Drug interaction, |
||||
TIRZEPATIDE, ZOLPIDEM TARTRATE, |
||||
| 673 | 25055728 |
US |
2 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 674 | 25055994 |
BR |
2 | |
Product adhesion issue, Therapy interrupted, |
||||
ROTIGOTINE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 675 | 25056096 |
CA |
32 | 1 |
Neutropenia, Neutropenia, Therapy interrupted, Leukopenia, |
||||
CLOZAPINE, |
||||
| 676 | 25054868 |
US |
||
Dysuria, Ejaculation disorder, Therapy interrupted, |
||||
TAMSULOSIN HYDROCHLORIDE, |
||||
| 677 | 25054870 |
US |
||
Therapy interrupted, |
||||
ISOTRETINOIN, |
||||
| 678 | 25054910 |
US |
68 | 2 |
Therapy interrupted, Off label use, |
||||
TRASTUZUMAB-ANNS, TRASTUZUMAB-ANNS, PERTUZUMAB, |
||||
| 679 | 25054939 |
US |
2 | |
Therapy interrupted, Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 680 | 25054999 |
US |
63 | 1 |
Psoriasis, Therapy interrupted, |
||||
APREMILAST, CARVEDILOL, LISINOPRIL, |
||||
| 681 | 25055125 |
US |
82 | 2 |
Sepsis, Mental status changes, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 682 | 25055130 |
US |
58 | 2 |
Psoriasis, Therapy interrupted, Discomfort, |
||||
APREMILAST, ANASTROZOLE, ANASTROZOLE TABLETS, HYDROCHLOROTHIAZIDE, LISINOPRIL, TIRZEPATIDE, |
||||
| 683 | 25055230 |
US |
||
Therapy interrupted, |
||||
| 684 | 25055368 |
US |
2 | |
Parkinson^s disease, Hallucination, Insomnia, Unevaluable event, Therapy interrupted, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 685 | 25055491 |
AT |
45 | 2 |
Cerebral venous sinus thrombosis, Therapeutic product effect decreased, Leukocytosis, Therapy interrupted, |
||||
ROMIPLOSTIM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ROMIPLOSTIM, |
||||
| 686 | 25048335 |
US |
1 | |
Therapy interrupted, Circumstance or information capable of leading to medication error, |
||||
ETANERCEPT, |
||||
| 687 | 25048343 |
CA |
||
Blood pressure increased, Heart rate decreased, Therapy interrupted, Intentional product use issue, |
||||
USTEKINUMAB, USTEKINUMAB-STBA, |
||||
| 688 | 25048365 |
CA |
54 | 2 |
Lichen sclerosus, Intentional underdose, Vulval cancer, Drug ineffective, Insurance issue, Therapy interrupted, Weight increased, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE, |
||||
| 689 | 25048444 |
US |
46 | 1 |
Pain, Therapy interrupted, |
||||
INTERFERON BETA-1A, |
||||
| 690 | 25048471 |
US |
||
Cough, Rhinorrhoea, Drug effective for unapproved indication, Product dose omission issue, Product packaging quantity issue, Therapy interrupted, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 691 | 25048528 |
US |
||
Spinal cord neoplasm, Aortic aneurysm, Therapy interrupted, |
||||
RELUGOLIX, ABIRATERONE ACETATE, PREDNISONE, LISINOPRIL, OXYCODONE, |
||||
| 692 | 25048963 |
US |
2 | |
Death, Neoplasm malignant, Brain operation, Nerve injury, Bedridden, Pain, Back pain, Malaise, Chest discomfort, Cough, Wheezing, Ill-defined disorder, Dyspnoea, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, RIFAMPIN, CLARITHROMYCIN, |
||||
| 693 | 25049243 |
US |
90 | 2 |
Liver disorder, Therapy interrupted, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 694 | 25049314 |
US |
31 | 1 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 695 | 25049594 |
CA |
2 | |
Pneumonia, Rheumatoid arthritis, Oropharyngeal pain, Cough, Inappropriate schedule of product administration, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FOLIC ACID, HYDROXYCHLOROQUINE, PANTOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 696 | 25049606 |
CO |
46 | 2 |
Knee arthroplasty, Wound cellulitis, Product prescribing issue, Therapy interrupted, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEFLUNOMIDE, |
||||
| 697 | 25049645 |
US |
1 | |
Surgery, Psoriasis, Product prescribing issue, Product dose omission issue, Product availability issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 698 | 25050202 |
US |
26 | 1 |
Pulmonary function test decreased, Cough, Insurance issue, Product dose omission issue, Therapy interrupted, Product distribution issue, Device issue, Drug dose omission by device, |
||||
AMIKACIN, AMIKACIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, OMADACYCLINE, |
||||
| 699 | 25050369 |
US |
2 | |
Knee arthroplasty, Therapy interrupted, |
||||
APREMILAST, |
||||
| 700 | 25050510 |
53 | 2 | |
Viral infection, Therapy interrupted, |
||||
ETANERCEPT, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28